Invention Grant
- Patent Title: Formulations for benzimidazolyl pyridyl ethers
- Patent Title (中): 苯并咪唑基吡啶醚的配方
-
Application No.: US12374383Application Date: 2007-07-20
-
Publication No.: US08455662B2Publication Date: 2013-06-04
- Inventor: Ahmad Hashash , Sean Ritchie , Kangwen Lin , Peng Shen , Augustus Okhamafe , Rampurna Gullapalli
- Applicant: Ahmad Hashash , Sean Ritchie , Kangwen Lin , Peng Shen , Augustus Okhamafe , Rampurna Gullapalli
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Foley & Lardner LLP
- International Application: PCT/US2007/016469 WO 20070720
- International Announcement: WO2008/011154 WO 20080124
- Main IPC: C07D235/00
- IPC: C07D235/00 ; C07D403/02 ; C07D401/00 ; A61K9/64 ; A61K9/48 ; A61K31/44 ; A01N43/40

Abstract:
Formulations are provided, comprising: a compound of Formula I, a pharmaceutically acceptable salt thereof, or a mixture of any two or more thereof; and an ingredient selected from a hydrophilic solvent, a lipophilic solvent, an emulsifier, or a mixture of any two or more thereof; wherein the compound of Formula I is: In some embodiments, the formulations are liquids. In other embodiments, the formulations are solids. Also provided are methods of preparing such formulations.
Public/Granted literature
- US20100040677A1 FORMULATIONS FOR BENZIMIDAZOLYL PYRIDYL ETHERS Public/Granted day:2010-02-18
Information query